Given IL-6's role in atrial remodeling and its association with left atrial enlargement, IL-6 blockade may offer a novel strategy to diminish atrial inflammatory matrix and slow progression of atrial fibrillation. The gene discussed is IL6; the disease is atrial fibrillation.